{
  "docId": "019de075-c130-77ea-b60f-b21955e0fc8e",
  "docSlug": "71c1598fd07d494c4a73d86584bdcfa9",
  "documentTitle": "Nuvalent | Investor Presentation Deck | 39 slides",
  "authorId": "nuvalent",
  "authorName": "Nuvalent",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-08-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 22,
  "pageCount": 39,
  "prevPage": 21,
  "nextPage": 23,
  "slideType": "traction",
  "function": "show_traction",
  "density": "dense",
  "nDataPoints": 4,
  "notes": "The chart is a swimmer plot (a common clinical trial visualization).",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de075-c130-77ea-b60f-b21955e0fc8e/22",
  "deckHref": "/decks/019de075-c130-77ea-b60f-b21955e0fc8e",
  "deckJsonHref": "/decks/019de075-c130-77ea-b60f-b21955e0fc8e.json",
  "deckAnchorHref": "/decks/019de075-c130-77ea-b60f-b21955e0fc8e#slide-22",
  "components": [
    {
      "bbox": {
        "h": 0.7,
        "w": 0.65,
        "x": 0.07,
        "y": 0.18
      },
      "kind": "chart",
      "text": "Swimmer plot of treatment duration by patient",
      "attrs": null,
      "subkind": "bar-horizontal",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "77bfa495-5701-4e01-ae6c-9459bab334a7",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.04,
        "w": 0.75,
        "x": 0.07,
        "y": 0.875
      },
      "kind": "disclaimer",
      "text": "Data as of 13 Sep 22, for response-evaluable patients with NSCLC treated by 01 Sep 2022. PD, progressive disease; PR, partial response; QD, once daily; TKI, tyrosine kinase inhibitor. Source: Drilon A. et al., EORTC-NCI-AACR 2022.",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "1e37abac-761d-4ec2-bf54-3517d036e680",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.21,
        "w": 0.22,
        "x": 0.715,
        "y": 0.36
      },
      "kind": "legend",
      "text": "Legend for treatment types, response status, and ongoing status",
      "attrs": null,
      "subkind": null,
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "e15e0721-2596-4656-8f59-cb7c002ac5b3",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.15,
        "w": 0.48,
        "x": 0.43,
        "y": 0.64
      },
      "kind": "list",
      "text": "76% (16/21) response-evaluable patients continue treatment; Median duration 3.6 months; No discontinuation due to toxicity; Median time to response 3.6 weeks",
      "attrs": null,
      "subkind": "bullet",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c2fc4d67-c4f3-4828-aa3e-cea691945a92",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.6,
        "x": 0.07,
        "y": 0.08
      },
      "kind": "title",
      "text": "Time on Treatment | Sustained Duration with Follow-up Ongoing",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "22adfc62-85ea-48fd-8447-a8e1df0a2be3",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [
    {
      "name": "Sparklines (Chart)",
      "slug": "sparklines-chart",
      "agent": "Designer",
      "layer": "slide",
      "matchId": "29000ee1-a04f-4dcc-92cf-a8121c6957e0",
      "evidence": "chart/bar-horizontal: Swimmer plot of treatment duration by patient",
      "confidence": 0.7
    }
  ],
  "frameworks": [],
  "arcBeats": [
    {
      "to": 24,
      "from": 19,
      "beatId": "fe8c99d1-59ae-4350-9a12-ffd07cd22e0a",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Traction",
      "beatSlug": null,
      "evidence": "Preliminary efficacy and safety data are presented.",
      "position": 3,
      "confidence": 0.8,
      "parentBeatName": null,
      "parentBeatSlug": null
    }
  ],
  "loops": [
    {
      "to": 24,
      "from": 19,
      "name": "Day In Life",
      "slug": "14-day-in-life",
      "bestFor": "Product demos, UX reviews, investor pitches focusing on pain points",
      "matchId": "a5849bfd-1f57-46db-8128-2b35af72eb66",
      "evidence": "Preliminary efficacy data are presented.",
      "position": 1,
      "objective": "How do patients benefit from Nuvalent's therapies?",
      "structure": "The User's Struggle -> The Intervention (Your Solution) -> The Resolved State",
      "confidence": 0.6,
      "description": "Humanize abstract data by walking through a single user's struggle and resolution"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}